These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10961766)

  • 61. Comprehensive/tertiary care for headache: a 6-month outcome study.
    Saper JR; Lake AE; Madden SF; Kreeger C
    Headache; 1999 Apr; 39(4):249-63. PubMed ID: 15613222
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 5HT in migraine patients with medication-induced headache.
    Hering R; Glover V; Pattichis K; Catarci T; Steiner TJ
    Cephalalgia; 1993 Dec; 13(6):410-2. PubMed ID: 8313455
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The comprehensive headache-related quality of life questionnaire shows significant improvement after withdrawal treatment in medication overuse headache: a pilot study.
    Gyüre T; Csépány É; Hajnal B; Kellermann I; Balogh E; Nagy Z; Manhalter N; Bozsik G; Ertsey C
    Ideggyogy Sz; 2014 May; 67(5-6):169-76; discussion 177. PubMed ID: 25087376
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcome of medication overuse headache after abrupt in-patient withdrawal.
    Relja G; Granato A; Bratina A; Antonello RM; Zorzon M
    Cephalalgia; 2006 May; 26(5):589-95. PubMed ID: 16674768
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness.
    Zeeberg P; Olesen J; Jensen R
    Cephalalgia; 2006 Oct; 26(10):1192-8. PubMed ID: 16961785
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: a comparison of two consecutive treatment methods in an open-label design.
    Munksgaard SB; Bendtsen L; Jensen RH
    Cephalalgia; 2012 Aug; 32(11):834-44. PubMed ID: 22751965
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Analgesic rebound headache in clinical practice: data from a physician survey.
    Rapoport A; Stang P; Gutterman DL; Cady R; Markley H; Weeks R; Saiers J; Fox AW
    Headache; 1996 Jan; 36(1):14-9. PubMed ID: 8666530
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Headache and migraine: a leading cause of absenteeism.
    Baigi K; Stewart WF
    Handb Clin Neurol; 2015; 131():447-63. PubMed ID: 26563803
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Chronic daily headache: management and rehabilitation].
    de Filippis S; Salvatori E; Coloprisco G; Martelletti P
    Clin Ter; 2006; 157(2):153-7. PubMed ID: 16817505
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Topiramate in the treatment of chronic migraine.
    Silvestrini M; Bartolini M; Coccia M; Baruffaldi R; Taffi R; Provinciali L
    Cephalalgia; 2003 Oct; 23(8):820-4. PubMed ID: 14510929
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Excessive acute migraine medication use and migraine progression.
    Bigal ME; Lipton RB
    Neurology; 2008 Nov; 71(22):1821-8. PubMed ID: 19029522
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prednisone as initial treatment of drug-induced daily headache.
    Spierings EL
    Cephalalgia; 2000 Oct; 20(8):748. PubMed ID: 11167906
    [No Abstract]   [Full Text] [Related]  

  • 74. Amitriptyline and dexamethasone combined treatment in drug-induced headache.
    Bonuccelli U; Nuti A; Lucetti C; Pavese N; Dell'Agnello G; Muratorio A
    Cephalalgia; 1996 May; 16(3):198-200. PubMed ID: 8734771
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Headaches associated with chronic use of analgesics: a therapeutic approach.
    Pini LA; Bigarelli M; Vitale G; Sternieri E
    Headache; 1996; 36(7):433-9. PubMed ID: 8783476
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy.
    Suhr B; Evers S; Bauer B; Gralow I; Grotemeyer KH; Husstedt IW
    Cephalalgia; 1999 Jan; 19(1):44-9. PubMed ID: 10099859
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A CARE: pathway in medication-overuse headache: the experience of the Headache Centre in Pavia.
    Sances G; Ghiotto N; Loi M; Guaschino E; Marchioni E; Catarci T; Nappi G
    J Headache Pain; 2005 Sep; 6(4):307-9. PubMed ID: 16362695
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse.
    Fritsche G; Eberl A; Katsarava Z; Limmroth V; Diener HC
    Eur Neurol; 2001; 45(4):229-35. PubMed ID: 11385260
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache.
    Lu SR; Fuh JL; Juang KD; Wang SJ
    Headache; 2000 Oct; 40(9):724-9. PubMed ID: 11091290
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rebound-withdrawal headache (medication overuse headache).
    Couch JR
    Curr Treat Options Neurol; 2006 Jan; 8(1):11-9. PubMed ID: 16343357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.